Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo

Gene Therapy

Volumn 20, Issue 9, 2013, Pages 893-900

  Zhang, H ^a   Yuan, Y L ^a   Wang, Z ^a   Jiang, B ^a   Zhang, C S ^a   Wang, Q ^a   Xu, X H ^a   Dong, H Y ^a   Zhang, Z M ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

angiogenesis; angiopoietin 1; gene control; ischemic myocardium; vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS MODULATOR; ANGIOPOIETIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PARVOVIRUS VECTOR; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 2;

ACUTE HEART INFARCTION; ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CAPILLARY DENSITY; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; IMMUNOFLUORESCENCE; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENO-ASSOCIATED VIRUS; ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANGIOPOIETIN-1; ANIMALS; CAPILLARY PERMEABILITY; CORONARY VESSELS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC THERAPY; HEART; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROVESSELS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RESPONSE ELEMENTS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883853329     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.12     Document Type: Article

References (31)

1. Simons M. Angiogenesis: where do we stand now? Circulation 2005; 111: 1556-1566. (Pubitemid 40470653)
2. Siddiqui J, Fischer H, Widegren U, Grinnemo KH, Hao X, Mansson-Broberg A et al. Depressed expression of angiogenic growth factors in the subacute phase of myocardial ischemia: a mechanism behind the remodeling plateau? Coron Artery Dis 2010; 21: 65-71.
3. Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM. Expression of VEGF and angiopoietins-1 and-2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol 2003; 285: H352-H358. (Pubitemid 36736449)
4. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14: 25-36.
5. Konstantin G, G Guillem, A Annika, B Christer. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29: 630-638.
6. Markus T, Hellmut GA. The role of the angiopoietins in vascular morphogenesis. Angiogenesis 2009; 12: 125-137.
7. Salmon AH, Neal CR, Sage LM, Glass CA, Harper SJ, Bates DO. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009; 83: 24-33.
8. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355-2360. (Pubitemid 39407339)
9. Zhang H, Dong HY, Jiang B, Wang Z, Chen R, Zhang Z et al. Hypoxic response elements and Tet-On advanced double-controlled systems regulate hVEGF165 and angiopoietin-1 gene expression in vitro. J Biomed Res 2011; 3: 204-212.
10. Carmeliet P, De Smet F, Loges S, Mazzone M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 2009; 6: 315-326.
11. Warren CM, Iruela-Arispea ML. Signaling circuitry in vascular morphogenesis. Curr Opin Hematol 2010; 17: 213-218.
12. Shyu K-G, Chang H, MI Jeffrey. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci 2003; 73: 563-579. (Pubitemid 36589036)
13. Zhou YF, Stabile E, Walker J, Shou M, Baffour R, Yu Z et al. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. Am Coll Cardiol 2004; 8: 897-903. (Pubitemid 39099591)
14. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-936. (Pubitemid 43093958)
15. Thurston G, Wang Q, Baffert F, Rudge J, Papadopoulos N, Jean-Guillaume D et al. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 2005; 132: 3317-3326. (Pubitemid 41167158)
16. Yana I, Sagara H, Takaki S, Takatsu K, Nakamura K, Nakao K et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J Cell Sci 2007; 120: 1607-1614. (Pubitemid 46831790)
17. van Hinsbergh VWM, Koolwijk P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 2008; 78: 203-212. (Pubitemid 351556093)
18. London NR, Whitehead KJ, Li DY. Endogenous endothelial cell signaling systems maintain vascular stability. Angiogenesis 2009; 12: 149-158.
19. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvis A, Abramsson A et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-1177. (Pubitemid 36870177)
20. Betsholtz C, Shima D. Spatially restricted patterning cues provided by heparinbinding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002; 16: 2684-2698.
21. Ye L, Haider HKh, Jiang S, Tan RS, Ge R, Law PK et al. Improved angiogenic response in pig heart following ischemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur J Heart Fail 2007; 9: 15-22. (Pubitemid 46074475)
22. Niagara MI, Haider HK, Ye L, Koh VS, Lim YT, Poh KK et al. Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia. J Vasc Surg 2004; 40: 774-785. (Pubitemid 39311647)
23. Vera Janavel G, Crottogini A, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M et al. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Therapy 2006; 13: 1133-1142. (Pubitemid 44101363)
24. Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, Xu X et al. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006; 98: 954-961.
25. Dong HY, Xu ZW, Zhang ZM, Yu HL, Xu XH. Mobilization of bone marrow-derived Nkx2-5(\+) cardiac progenitor cells under condition of acute myocardial ischemia. Acta Physiol Sin 2009; 61: 185-193.
26. Jiang B, Dong HY, Zhang ZM, Wang W, Zhang YQ, Xu XH. Hypoxic response elements control expression of human vascular endothelial growth factor165 genes transferred to ischemia myocardium in vivo and in vitro. J Gene Med 2007; 9: 788-796. (Pubitemid 47386863)
27. Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with longterm doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 2002; 76: 11605-11611. (Pubitemid 35231316)
28. Dong HY, Wang Q, Zhang YQ, Jiang B, Xu XH, Zhang ZM. Angiogenesis induced by hVEGF165 gene controlled by hypoxic response elements in rabbit ischemia myocardium. Exp Biol Med 2009; 234: 1417-1424.
29. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. Micro-RNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
30. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivelä A et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029-1035. (Pubitemid 38282857)
31. Emanueli C, Grady EF, Madeddu P, Figin M, Bunnett NW, Parisi D et al. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension 1998; 31: 1299-1304. (Pubitemid 28248831)